(Q48823169)

15 February 2018

title

The CSF levels of total-tau and phosphotau in patients with relapsing-remitting multiple sclerosis. (English)

1 reference

15 February 2018

relapsing-remitting multiple sclerosis

main subject

0 references

multiple sclerosis

0 references

author

Halina Bartosik-Psujek

series ordinal

1

object named as

H Bartosik-Psujek

1 reference

15 February 2018

author name string

Z Stelmasiak

series ordinal

2

1 reference

15 February 2018

publication date

6 July 2005

1 reference

15 February 2018

Journal of Neural Transmission

published in

1 reference

15 February 2018

volume

113

1 reference

15 February 2018

issue

3

1 reference

15 February 2018

page(s)

339-345

1 reference

15 February 2018

https://scigraph.springernature.com/pub.10.1007/s00702-005-0327-z

exact match

0 references

cites work

Tau alteration and neuronal degeneration in tauopathies: mechanisms and models

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00702-005-0327-Z

Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00702-005-0327-Z

CSF phosphorylated tau is a possible marker for discriminating Alzheimer's disease from dementia with Lewy bodies. Phospho-Tau International Study Group.

21 January 2018

1 reference

12 December 2020

Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231.

1 reference

12 December 2020

Tau-mediated cytotoxicity in a pseudohyperphosphorylation model of Alzheimer's disease.

1 reference

12 December 2020

Cerebrospinal fluid tau levels increase with age in healthy individuals.

1 reference

12 December 2020

Biochemical diagnosis of Alzheimer disease by measuring the cerebrospinal fluid ratio of phosphorylated tau protein to beta-amyloid peptide42.

1 reference

12 December 2020

1 reference

12 December 2020

Tau protein and 14-3-3 are elevated in the cerebrospinal fluid of patients with multiple sclerosis and correlate with intrathecal synthesis of IgG.

1 reference

12 December 2020

Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias

1 reference

12 December 2020

Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?

1 reference

12 December 2020

Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time.

1 reference

12 December 2020

Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles

1 reference

12 December 2020

Tau protein in cerebrospinal fluid: a possible marker of poor outcome in patients with early relapsing-remitting multiple sclerosis.

1 reference

12 December 2020

Tau protein and the neurofibrillary pathology of Alzheimer's disease

1 reference

12 December 2020

Tau protein in cerebrospinal fluid (CSF): a blood-CSF barrier related evaluation in patients with various neurological diseases.

1 reference

12 December 2020

Increased cerebrospinal fluid tau protein in multiple sclerosis

1 reference

12 December 2020

Hyperphosphorylation and aggregation of tau in experimental autoimmune encephalomyelitis

1 reference

12 December 2020

Elevated total tau/phospho-tau ratio in autopsy-proven Creutzfeldt-Jakob disease with negative 14-3-3 test results

1 reference

12 December 2020

Total tau and phosphorylated tau 181 levels in the cerebrospinal fluid of patients with frontotemporal dementia due to P301L and G272V tau mutations

1 reference

12 December 2020

Functions and malfunctions of the tau proteins

1 reference

12 December 2020

Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt–Jakob disease

1 reference

12 December 2020

The 14-3-3 protein in multiple sclerosis: a marker of disease severity

1 reference

12 December 2020

Tau protein concentrations in cerebrospinal fluid of patients with multiple sclerosis

1 reference

12 December 2020

Critique of experimental trials of therapy in multiple sclerosis

1 reference

12 December 2020

10.1007/S00702-005-0327-Z

Identifiers

DOI

1 reference

15 February 2018

1 reference

15 February 2018